Articles Policy Forum Jul 2003 Undergraduate and Graduate Medical Education and the Pharmaceutical Industry Greg E. Manship, MDiv, MA Virtual Mentor. 2003;5(7):268-272. doi: 10.1001/virtualmentor.2003.5.7.pfor1-0307. Case and Commentary Jul 2003 Clinician and Researcher, Commentary 1 Timothy F. Murphy, PhD Virtual Mentor. 2003;5(7):247-250. doi: 10.1001/virtualmentor.2003.5.7.ccas2-0307. Medical Education Jul 2003 Commercial Support for Continuing Medical Education Murray Kopelow, MD Virtual Mentor. 2003;5(7):255-259. doi: 10.1001/virtualmentor.2003.5.7.medu1-0307. Viewpoint Jul 2003 Safeguarding the Quality of Clinical Research Joel Lexchin, MD Virtual Mentor. 2003;5(7):283-285. doi: 10.1001/virtualmentor.2003.5.7.oped1-0307. Case and Commentary Jul 2003 Drug Company Sponsorship of Clinical Conferences, Commentary 1 Robert Goodman, MD Virtual Mentor. 2003;5(7):239-241. doi: 10.1001/virtualmentor.2003.5.7.ccas1-0307. Case and Commentary Jul 2003 Drug Company Sponsorship of Clinical Conferences, Commentary 2 Ashley Wazana, MD Virtual Mentor. 2003;5(7):242-246. doi: 10.1001/virtualmentor.2003.5.7.ccas1-0307. AMA Code Says Jul 2003 The Code on Physicians' Relationship with Industry Audiey C. Kao, MD, PhD Virtual Mentor. 2003;5(7):263-264. doi: 10.1001/virtualmentor.2003.5.7.code1-0307. State of the Art and Science Jul 2003 Treating Hypertension Audiey C. Kao, MD, PhD Virtual Mentor. 2003;5(7):265-267. doi: 10.1001/virtualmentor.2003.5.7.cprl1-0307. Policy Forum Jul 2003 The PhRMA Code: A New Roadmap for Industry-Physician Interactions Michael Scott Labson, Esq Virtual Mentor. 2003;5(7):273-275. doi: 10.1001/virtualmentor.2003.5.7.pfor2-0307. From the Editor Jul 2003 Match Made of Necessity Audiey C. Kao, MD, PhD Virtual Mentor. 2003;5(7):237-238. doi: 10.1001/virtualmentor.2003.5.7.fred1-0307. Pagination First page « First Previous page ‹ Prev … Page 361 Page 362 Page 363 Page 364 Current page 365 Page 366 Page 367 Page 368 Page 369 … Next page Next › Last page Last »
Policy Forum Jul 2003 Undergraduate and Graduate Medical Education and the Pharmaceutical Industry Greg E. Manship, MDiv, MA Virtual Mentor. 2003;5(7):268-272. doi: 10.1001/virtualmentor.2003.5.7.pfor1-0307.
Case and Commentary Jul 2003 Clinician and Researcher, Commentary 1 Timothy F. Murphy, PhD Virtual Mentor. 2003;5(7):247-250. doi: 10.1001/virtualmentor.2003.5.7.ccas2-0307.
Medical Education Jul 2003 Commercial Support for Continuing Medical Education Murray Kopelow, MD Virtual Mentor. 2003;5(7):255-259. doi: 10.1001/virtualmentor.2003.5.7.medu1-0307.
Viewpoint Jul 2003 Safeguarding the Quality of Clinical Research Joel Lexchin, MD Virtual Mentor. 2003;5(7):283-285. doi: 10.1001/virtualmentor.2003.5.7.oped1-0307.
Case and Commentary Jul 2003 Drug Company Sponsorship of Clinical Conferences, Commentary 1 Robert Goodman, MD Virtual Mentor. 2003;5(7):239-241. doi: 10.1001/virtualmentor.2003.5.7.ccas1-0307.
Case and Commentary Jul 2003 Drug Company Sponsorship of Clinical Conferences, Commentary 2 Ashley Wazana, MD Virtual Mentor. 2003;5(7):242-246. doi: 10.1001/virtualmentor.2003.5.7.ccas1-0307.
AMA Code Says Jul 2003 The Code on Physicians' Relationship with Industry Audiey C. Kao, MD, PhD Virtual Mentor. 2003;5(7):263-264. doi: 10.1001/virtualmentor.2003.5.7.code1-0307.
State of the Art and Science Jul 2003 Treating Hypertension Audiey C. Kao, MD, PhD Virtual Mentor. 2003;5(7):265-267. doi: 10.1001/virtualmentor.2003.5.7.cprl1-0307.
Policy Forum Jul 2003 The PhRMA Code: A New Roadmap for Industry-Physician Interactions Michael Scott Labson, Esq Virtual Mentor. 2003;5(7):273-275. doi: 10.1001/virtualmentor.2003.5.7.pfor2-0307.
From the Editor Jul 2003 Match Made of Necessity Audiey C. Kao, MD, PhD Virtual Mentor. 2003;5(7):237-238. doi: 10.1001/virtualmentor.2003.5.7.fred1-0307.